retatrutide mechanism retatrutide clinical trials 2024 2025 trial results press release A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Lilly's triple agonist, retatrutide, delivered – 🎙️ NEW EPISODE: Retatrutide—The Triple

US$ 23.43

★★★★★ 4.6 (15 reviews)

US$ 24.31

★★★★★ 4.5 (6 reviews)

US$ 25.96

★★★★★ 4.9 (8 reviews)

US$ 29.33

★★★★★ 4.4 (20 reviews)

US$ 22.99

★★★★★ 4.0 (14 reviews)

US$ 23.88

★★★★★ 4.3 (8 reviews)

US$ 28.11

★★★★★ 4.4 (30 reviews)

US$ 24.92

★★★★★ 4.5 (10 reviews)

US$ 26.59

★★★★★ 5.0 (17 reviews)

US$ 29.66

★★★★★ 4.3 (19 reviews)

US$ 25.96

★★★★★ 4.6 (27 reviews)

US$ 25.44

★★★★★ 4.4 (9 reviews)

US$ 24.65

★★★★★ 4.7 (10 reviews)

US$ 21.59

★★★★★ 4.0 (30 reviews)

US$ 24.91

★★★★★ 4.1 (13 reviews)

US$ 28.55

★★★★★ 4.7 (23 reviews)

US$ 22.35

★★★★★ 5.0 (20 reviews)

US$ 27.82

★★★★★ 4.1 (18 reviews)

US$ 23.09

★★★★★ 4.6 (28 reviews)

US$ 23.59

★★★★★ 4.1 (12 reviews)